Beacon Investment Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-240
Closed -$4.6K – 845
2026
Q1
$4.6K Buy
+240
New +$5.21K ﹤0.01% 703
2025
Q1
– Sell
-18,905
Closed -$681K – 252
2024
Q4
$681K Sell
18,905
-13,705
-42% -$464K 0.03% 154
2024
Q3
$1.38M Sell
32,610
-970
-3% -$41.1K 0.06% 129
2024
Q2
$1.35M Sell
33,580
-2,883
-8% -$120K 0.06% 126
2024
Q1
$1.29M Sell
36,463
-1,467
-4% -$39.3K 0.06% 126
2023
Q4
$1.12M Sell
37,930
-4,031
-10% -$83.6K 0.05% 134
2023
Q3
$872K Sell
41,961
-779
-2% -$21.4K 0.04% 153
2023
Q2
$1.05M Buy
42,740
+17,326
+68% +$557K 0.05% 152
2023
Q1
$1.03M Sell
25,414
-3,710
-13% -$154K 0.05% 147
2022
Q4
$1.31M Buy
29,124
+2,215
+8% +$100K 0.07% 136
2022
Q3
$1.29M Buy
26,909
+4,359
+19% +$239K 0.07% 134
2022
Q2
$1.33M Buy
22,550
+1,126
+5% +$92.4K 0.07% 137
2022
Q1
$2.49M Buy
21,424
+1,622
+8% +$189K 0.11% 121
2021
Q4
$2.98M Buy
19,802
+1,618
+9% +$218K 0.12% 121
2021
Q3
$2.17M Buy
18,184
+3,568
+24% +$393K 0.09% 130
2021
Q2
$1.42M Buy
14,616
+1,725
+13% +$154K 0.06% 151
2021
Q1
$1.14M Buy
12,891
+3,487
+37% +$324K 0.05% 156
2020
Q4
$900K Buy
9,404
+3,092
+49% +$319K 0.04% 155
2020
Q3
$716K Buy
6,312
+407
+7% +$42.8K 0.04% 154
2020
Q2
$584K Buy
5,905
+1,509
+34% +$120K 0.03% 160
2020
Q1
$283K Buy
+4,396
New +$308K 0.02% 199

Other funds holding TNDM

Beacon Investment Advisory Services's TNDM Position: Q2 2026 in Review

Beacon Investment Advisory Services sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 240 shares — an estimated $4.6K sold.

Beacon Investment Advisory Services first reported a position in TNDM in Q1 2020 and held it in 21 quarters. The position peaked at $2.98M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Beacon Investment Advisory Services reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Beacon Investment Advisory Services sold 240 Tandem Diabetes Care shares in Q2 2026, an estimated $4.6K.
  • Beacon Investment Advisory Services first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 21 quarters.
  • Beacon Investment Advisory Services's Tandem Diabetes Care position peaked at $2.98M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.